XINHUA PHARM(SZ:000756)2022-12-08 05:22Group 1: Company Overview - Founded in 1943, Shandong Xinhua Pharmaceutical Co., Ltd. is the largest producer and exporter of antipyretic and analgesic drugs in Asia, and a significant manufacturer of cardiovascular, anti-infection, and central nervous system drugs [2] - The company produces over 300 varieties of products, including chemical raw materials, pharmaceutical preparations, intermediates, and chemical materials [3] Group 2: Production Capacity - Annual production capacity for chemical raw materials is 25,000 tons, making it the largest producer of drugs such as Anacin, Ibuprofen, Aspirin, and Caffeine globally [3] - The production capacity for pharmaceutical preparations includes 8 billion tablets, 300 million injections, and 200 million capsules annually [3] Group 3: Sales Performance - In the first half of 2014, raw material drug exports and domestic sales increased by 9% and 10% respectively, with significant sales growth for key products like Caffeine and Levodopa [3] - Sales of pharmaceutical preparations grew by 11.5% year-on-year, with new products such as Jiahualuo, Jiening, and Shutaide maintaining rapid sales growth [3] Group 4: Financial Performance - For the first half of 2014, the company achieved operating revenue of RMB 1,736,817 thousand, a 7.40% increase compared to the same period last year [3] - The operating profit was RMB 23,570 thousand, a significant turnaround from an operating loss of RMB 13,046 thousand in the previous year, attributed to technological advancements and cost reduction efforts [3]